Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -1.38% | 159.68 | 0.7% | $1250.87m | |
| LLY | Eli Lilly & Co. | -1.68% | 327.36 | 1.1% | $1087.51m | |
| ABBV | AbbVie, Inc. | -1.27% | 138.51 | 1.9% | $849.63m | |
| PFE | Pfizer Inc. | -2.21% | 42.14 | 0.9% | $785.56m | |
| BMY | Bristol-Myers Squibb Co. | -0.58% | 69.84 | 1.0% | $747.51m | |
| MRK | Merck & Co., Inc. | -0.15% | 87.31 | 0.7% | $696.62m | |
| AZN | AstraZeneca Plc | 1.24% | 55.59 | 1.0% | $390.97m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -2.17% | 197.98 | 8.2% | $219.95m | |
| GSK | GSK Plc | 0.57% | 30.17 | 0.3% | $209.70m | |
| NVS | Novartis AG | -0.54% | 75.63 | 0.2% | $199.82m | |
| HZNP | Horizon Therapeutics Plc | -3.48% | 65.53 | 5.4% | $182.14m | |
| GBT | Global Blood Therapeutics, Inc. | 0.00% | 68.49 | 5.4% | $178.81m | |
| IDXX | IDEXX Laboratories, Inc. | -3.42% | 334.21 | 3.9% | $178.04m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.37% | 112.10 | 12.4% | $138.37m | |
| AKRO | Akero Therapeutics, Inc. | -0.53% | 39.05 | 0.0% | $133.45m |
Company Profile
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.